A randomized trial indicates routine prophylactic sucralfate does not reduce opioid use or significantly decrease grade 2–3 radiation esophagitis in high-risk patients receiving thoracic radiotherapy, supporting its use as a reactive rather than preventive intervention. | Shin, Pract Radiat Oncol 2026
